Consistent with findings in HCC, low ZHX2 expression correlates with poor prognosis of thyroid cancer (7), multiple myeloma (8–10), and chronic lymphocytic leukemia (11, 12). The gene discussed is ZHX2; the disease is hepatocellular carcinoma.